SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Genaissance Pharmaceuticals (GNSC)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jim Oravetz who started this subject9/11/2003 6:43:14 PM
From: nigel bates   of 183
 
United States Patent Application 20030165844
Kind Code A1
Anastasio, Alison E. ;   et al. September 4, 2003
------------------------------------------------------------------------
Haplotypes of the TNFRSF1A gene

Abstract
Novel genetic variants of the Tumor Necrosis Factor Receptor Superfamily, Member 1A (TNFRSF1A) gene are described. Various genotypes, haplotypes, and haplotype pairs that exist in the general United States population are disclosed for the TNFRSF1A gene. Compositions and methods for haplotyping and/or genotyping the TNFRSF1A gene in an individual are also disclosed. Polynucleotides defined by the haplotypes disclosed herein are also described.

------------------------------------------------------------------------
Inventors: Anastasio, Alison E.; (New Haven, CT) ; Chew, Anne; (Brookline, MA) ; Denton, R. Rex; (Madison, CT) ; Nandabalan, Krishnan; (Guilford, CT) ; Parks, Katie E.; (Naugatuck, CT) ; Stephens, J. Claiborne; (Guilford, CT)
Correspondence Name and Address: GENAISSANCE PHARMACEUTICALS
5 SCIENCE PARK
NEW HAVEN
CT
06511
US

Assignee Name and Adress: Genaissance Pharmaceuticals, Inc.

Serial No.: 945505
Series Code: 09
Filed: August 31, 2001
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext